- Ring The Bell
- Posts
- đź’µ Investors Are Scooping Up These ETFs Ahead Of The Fed's Rate Cuts
đź’µ Investors Are Scooping Up These ETFs Ahead Of The Fed's Rate Cuts
As the Fed gears up for rate cuts, investors are buying these ETFs. Plus, why one CEO is bullish on a deal going through, even if the market doesn't appear convinced
You're receiving this email because you're subscribed to Ring the Bell from Benzinga. To manage your subscription, click the link at the bottom of this email.
Happy Wednesday! It’s cut day! Hopefully my barber doesn’t take too much off ✂️. Oh wait, something else is getting cut today too? Here are some of the ETFs that investors are buying up in anticipation of the Fed cutting rates, plus, despite heavy scrutiny, the CEO of this company thinks the deal is going through.
—Aaron Bry
Plus, want to participate in gold’s historic rally? Check out today’s partner.
MARKET SNAPSHOT
Yesterday: The S&P hit new all-time highs (briefly) as investors gear up for lower interest rates. Enphase and other solar stocks were some of the big winners of the day.
On Our Radar: 2pm is decision time. Then, maybe more importantly, Powell will take the podium at 2:30pm ET and give us some insights into the Fed’s position moving forward. Buckle up, and be ready for some volatility!
TOP STORY
Basically: The Federal Reserve is widely anticipated to cut interest rates at its upcoming Federal Open Market Committee meeting, with the decision set for release on Wednesday at 2 p.m. ET.
Basically: The central bank has maintained the federal funds rate at 5.25%-5.5% since September 2023 and this week’s rate reduction would be the first since March 2020, signaling a marked shift from the restrictive monetary policy stance implemented to combat soaring inflation. And here are the ETFs that investors are rushing out to buy ahead of the planned cuts.
PRESENTED BY PRIORITY GOLD
Silver prices have soared in 2024, reaching levels not seen in over a decade. A supply crunch mixed with growing industrial demand – particularly in green technologies – was good news for silver investors.
Silver IRAs are a unique opportunity for those planning for retirement. Silver's dual role as both a precious metal as well as an industrial commodity makes it a potentially compelling choice and a hedge against economic uncertainties.
Priority Gold, a leader in precious metals IRAs, provides detailed insights for incorporating silver into your retirement strategy. By adding a Silver IRA through Priority Gold, investors could take advantage of any continued upward swing in silver.
If you want to make the most of silver's golden moment, visit PriorityGold.com to learn how a Silver IRA can enhance and shield your retirement savings.
FIVE ZINGERS
A Win’s A Win: Google has faced some major hurdles in Europe, but could a recent win in the courtroom give the stock a boost?
To The Moon: $LUNR stock is taking off on news that it secured a contract with NASA that could be worth nearly $5 billion.
Decision Day: Investors are torn on if the Fed will cut by 25 or 50 bps this afternoon. Here’s what could happen in either scenario.
Taking Profits: Insiders are selling shares at Coinbase, Electronic Arts and these two other companies.
Your Chance At $30k Risk-Free: Benzinga's World Championship of Trading is about to take off, and all you have to do is sign up and paper trade for your chance at the prizes.
ONE FOR THE ROAD
Basically: United States Steel Corporation CEO David Burritt says he is confident that the company's potential merger with Japan's Nippon steal will go through, despite the Biden administration’s opposition to the deal.
So: In a speech to the Detroit Economic Club Tuesday, Burritt said that the acquisition would be good for both shareholders and employees. Here’s what the potential deal means for the stock.
PRESENTED BY TELOMIR
When it comes to anti-aging much of the focus is on humans, but pets matter too. Helping them live longer and healthier is the main focus of Telomir Pharmaceuticals Inc. (NASDAQ: TELO) recent trial of its novel drug compound Telomir-1. The results were part of an exclusive ABC News segment in which Telomir revealed the potential for this drug.
Zeus and Benson, two senior dogs from Donte’s Den rescue organization in Myakka City, Florida, were both treated with Telomir-1. After getting the drug, both dogs exhibited improvements in their health conditions, according to Telomir. Zeus, a 12-year-old German Shepherd, showed complete remission of terminal cancer, while Benson, a 12-year-old Newfoundland suffering from severe arthritis, regained his mobility, leading to what caretakers described as a miraculous recovery, reports Telomir.
"The results seen in this study are a testament to the groundbreaking potential of Telomir-1,” said Telomir CEO Erez Aminov. To learn more about this potentially revolutionary treatment, click here.
BEFORE YOU GO
Were you forwarded this email? Click here to subscribe.
And be sure to check out our other newsletters:
Future Finance: Where fintech, crypto, and the future of finance collide. Future Finance is a perfect lunch read packed with quick bites for industry enthusiasts. Subscribe here.
Cannabis Daily: A must-read daily briefing for cannabis investors, operators, and enthusiasts. Join our list of industry veterans to jump start your morning. Subscribe here.
Real Estate Weekly: Where we highlight the movers and the losers, the upgrades and the downgrades, the top stories and opportunities in the trillion dollar REIT and real asset industry. Subscribe here.
Mining Weekly: Get an insider's edge with news, analysis, and commentary on what’s shaping the mining and commodities industry that powers the global economy. Subscribe here.
Advisor: Tailor-made for Financial Advisors, this weekly newsletter has industry-specific insights, analysis, and news. Subscribe here.